Fatal Stevens-Johnson Syndrome in an AIDS Patient Treated with Sulfadiazine

Abstract

Get full access to this article

View all access options for this article.

References

Haverkos

. Assessment of therapy for toxoplasma encephalitis. The TE study group. Am J Med 1987;82: 907–14.

Leport

Raffi

Matheron

Katlama

Regnier

Saimot

Treatment of central nervous system toxoplasmosis with pyrimethamine/ sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med 1988;84: 94–100.

Barditch-Crovo

Chaisson

. Adverse reactions to therapy for HIV infection. Emerg Med Clin North Am 1995;13: 133–47.

Murray

Camp

. Cephalexin-induced Stevens—Johnson syndrome. Ann Pharmacother 1992;26: 1230–3.

Roujeau

Chosidow

Saiag

Guillaume

. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990;23: 1039–58.

Nunn

Gicheha

Hayes

Gathua

Brindle

Kibuga

Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya. Tuber Lung Dis 1992;73:45–51.

Caumes

Bocquet

Guermonprez

Rogeaux

Bricaire

Katlama

Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis. Clin Infect Dis 1995;21:656–8.

Wolkenstein

Revuz

. Drug-induced severe skin reactions. Incidence, management and prevention. Drug Saf 1995;13: 56–68.

Dannemann

McCutchan

Israelski

Antoniskis

Leport

Luft

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 1992;116: 33–43.

10.

Fung

Kirschenbaum

. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 1996;18: 1037–56.